Oragenics, Inc.
OGEN · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,568 | -$20,656 | -$14,288 | -$15,712 |
| Dep. & Amort. | $0 | $27 | $45 | $41 |
| Deferred Tax | $0 | $0 | $0 | -$1,767 |
| Stock-Based Comp. | $516 | $1,017 | $742 | $1,688 |
| Change in WC | $1,454 | $2,017 | -$1,716 | $512 |
| Other Non-Cash | $0 | $10,303 | -$11 | $1,767 |
| Operating Cash Flow | -$8,597 | -$7,291 | -$15,228 | -$13,470 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1,000 | -$128 | -$44 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $64 | $12 | $0 |
| Investing Cash Flow | $0 | -$936 | -$116 | -$44 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$693 | -$566 | -$564 | -$525 |
| Stock Issued | $6,672 | $850 | $69 | $29,301 |
| Stock Repurch. | $0 | $0 | $0 | -$5,636 |
| Dividends Paid | $0 | $0 | $0 | -$1,118 |
| Other Fin. Act. | $0 | $0 | $0 | $1,118 |
| Financing Cash Flow | $5,979 | $284 | -$495 | $23,140 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,619 | -$7,943 | -$15,839 | $9,626 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,484 | $11,427 | $27,266 | $17,640 |
| End Cash | $865 | $3,484 | $11,427 | $27,266 |
| Free Cash Flow | -$8,597 | -$8,291 | -$15,356 | -$13,514 |